Because there seems to be some confusion about "ma
Post# of 72440
Quote:
A merger, acquisition, or consolidation with another company
The sale of company securities including equity or debt, and their derivatives, either privately or in the public markets
The sale of company assets or divisions including offices, land, products, intellectual property
An event which materially changes the company’s tax and/or corporate structure. For example, changing from for-profit to non-profit status
A change in the composition of the company’s board of directors or other governing body
An audit of your financials or other records by an outside expert
Entering into a major, strategic alliance with another company, organization or person
A change in the company’s legal status such as the dissolution or liquidation of the business, bankruptcy, or receivership
https://www.ansarada.com/blog/material-events
There is no need to send out a press release every time a company does something that is normal business -- for instance, actually starting enrollment in a clinical trial, especially if the company has already stated that they were doing so. Can you imagine how many press releases would go out if companies PR'ed every time they did normal business operations?
I do understand, but certainly do not sympathize with, the frustration of the shorts when the IPIX CEO does not divulge information which might give them opportunities to misrepresent and bash the company, or perhaps even to try to interfere with clinical trials, as some companies have reported in the past.